Carcinogen-Induced DNA Double Strand Break Repair in Sporadic Breast Cancer

Journal of Surgical Research

Volumn 135, Issue 1, 2006, Pages 120-128

  Zhang, Cindy ^a   Naftalis, Elizabeth ^a   Euhus, David ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

benzo a pyrene; breast neoplasms; comet assay; DNA repair; ionizing radiation; peripheral blood mononuclear cells; single nucleotide polymorphisms

Indexed keywords

BENZO[A]PYRENE; BIOLOGICAL MARKER; CARCINOGEN; DOUBLE STRANDED DNA;

ADULT; ARTICLE; BREAST CANCER; CARCINOGEN DNA INTERACTION; CLINICAL ARTICLE; COMET ASSAY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA REPAIR; DNA STRAND BREAKAGE; FEMALE; GENE LOCUS; GENOTYPE; HUMAN; HUMAN CELL; IONIZING RADIATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RADIATION EXPOSURE; STATISTICAL SIGNIFICANCE;

BENZO(A)PYRENE; BLEOMYCIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CARCINOGENS; COMET ASSAY; DNA; DNA DAMAGE; DNA REPAIR; FEMALE; GENOTYPE; HUMANS; LEUKOCYTES, MONONUCLEAR; METHYLNITRONITROSOGUANIDINE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIATION, IONIZING; UBIQUITIN-PROTEIN LIGASES;

EID: 33747040236     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.02.057     Document Type: Article

References (43)

1. Abaji C., Cousineau I., and Belmaaza A. BRCA2 regulates homologous recombination in response to DNA damage. Implications for genome stability and carcinogenesis. Cancer Res 65 (2005) 4117
2. Scully R., Xie A., and Nagaraju G. Molecular functions of BRCA1 in the DNA damage response. [Review] [111 refs]. Cancer Biol Ther 3 (2004) 521
3. Easton D.F., Ford D., and Bishop T. Breast and ovarian cancer incidence in BRCA1-mutation carriers. The Breast Cancer Linkage Consortium. Am J Hum Genet 56 (1995) 265
4. Schubert E.L., Lee M.K., Mefford H.C., et al. BRCA2 in American families with four or more cases of breast or ovarian cancer. Recurrent and novel mutations, variable expression, penetrance and the possibility of families whose cancer is not attributable to BRCA1 and BRCA2. Am J Hum Genet 60 (1997) 1031
5. Thorlacius S., Sigurdsson S., Bjarnadottir H., et al. Study of a single BRCA2 mutation with a high carrier frequency in a small population. Am J Hum Genet 60 (1997) 1079
6. Claus E.B., Schildkraut J.M., Thompson W.D., and Risch N.J. The genetic attributable risk of breast and ovarian cancer. Cancer 77 (1996) 2318
7. Parshad R., Price F.M., Bohr V.A., Cowans K.H., Zujewski J.A., and Sanford K.K. Deficient DNA repair capacity, a predisposing factor in breast cancer. Br J Cancer 74 (1996) 1
8. Patel R.K., Trivedi A.H., Arora D.C., Bhatavdekar J.M., and Patel D.D. DNA repair proficiency in breast cancer patients and their first degree relatives. Int J Cancer 73 (1997) 20
9. Scott D., Barber J.B., Spreadborough A.R., Burrill W., and Roberts S.A. Increased chromosomal radiosensitivity in breast cancer patients. A comparison of two assays. Int J Radiat Biol 75 (1999) 1
10. Roy S.K., Trivedi A.H., Bakshi S.R., et al. Spontaneous chromosomal instability in breast cancer families. Cancer Genet Cytogenet 118 (2000) 52
11. Hsu T.C., Johnston D.A., Cherry L.M., et al. Sensitivity to genotoxic effects of bleomycin in humans. Possible relationship to environmental carcinogenesis. Int J Cancer 43 (1989) 403
12. Rajeswari N., Ahuja Y.R., Malini U., et al. Risk assessment in the first degree female relatives of breast cancer patients using the alkaline Comet assay. Carcinogenesis 21 (2000) 557
13. Moller P. Genotoxicity of environmental agents assessed by the alkaline comet assay. [Review] [410 refs]. Basic Clin Pharmacol Toxicol 96 (2005) 1
14. Olive P.L., Wlodek D., and Banath J.P. DNA double-strand breaks measured in individual cells subjected to gel electrophoresis. Cancer Res 51 (1991) 4671
15. Nascimento P.A., da Silva M.A., Oliveira E.M., Suzuki M.F., and Okazaki K. Evaluation of radioinduced damage and repair capacity in blood lymphocytes of breast cancer patients. Braz J Med Biol Res 34 (2001) 165
16. Sanchez P., Penarroja R., Gallegos F., Bravo J.L., Rojas E., and Benitez-Bribiesca L. DNA damage in peripheral lymphocytes of untreated breast cancer patients. Arch Med Res 35 (2004) 480
17. Trivedi A.H., Roy S.K., Bhachech S.H., et al. Cytogenetic evaluation of 20 sporadic breast cancer patients and their first degree relatives. Breast Cancer Res Treat 48 (1998) 187
18. Jeffy B.D., Chirnomas R.B., and Romagnolo D.F. Epigenetics of breast cancer. Polycyclic aromatic hydrocarbons as risk factors. Environ Mol Mutagen 39 (2002) 235
19. Ames B.N., McCann J., and Yamasaki E. Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mitagenicity test. Mutation Res 31 (1975) 347
20. Singh N.P., McCoy M.T., Tice R.R., and Schnieder E.L. A simple technique for quantification of low levels of DNA damage in individual cells. Exp Cell Res 175 (1988) 184
21. Nadin S.B., Vargas-Roig L.M., and Ciocca D.R. A silver staining method for single-cell gel assay. J Histochem Cytochem 49 (2001) 1183
22. Piggee C.A., Muth J., Carrilho E., and Karger B.L. Capillary electrophoresis for the detection of known point mutations by single-nucleotide primer extension and laser-induced fluorescence detection. J Chromatogr A 781 (1997) 367
23. Berry D.A., Iversen Jr. E.S., Gudbjartsson D.F., et al. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. [see comment]. J Clin Oncol 20 (2002) 2701
24. Schabath M.B., Spitz M.R., Grossman H.B., et al. Genetic instability in bladder cancer assessed by the comet assay. J Natl Cancer Inst 95 (2003) 540
25. Yang H., Mazur-Melnyk M., de Boer J.G., and Glickman B.W. A comparison of mutational specificity of mutations induce by S9-activated B[a]P and benzo[a]pyrene-7,8-diol-9,10-epoxide at the endogenous aprt gene in CHO cells. Mutation Res 423 (1999) 23
26. Savela K., King L., Gallagher J., and Lewtas J. 32P-postlabeling and HPLC separation of DNA adducts formed by diesel exhaust extracts in vitro and in mouse skin and lung after topical treatment. Carcinogenesis 16 (1995) 2083
27. Knight R.D., Parshad R., Price F.M., Tarone R.E., and Sanfor K.K. X-ray-induced chromatid damage in relation to DNA repair and cancer incidence in family members. Int J Cancer 54 (1993) 89
28. Kaur T.B., Travaline J.M., Gaughan J.P., Richie J.P., Stellman S.D., and Lazarus P. Role of polymorphisms in condons 143 and 160 of the O6-alkylguanine DNA alkyltransferase gene in lung cancer risk. Cancer Epidemiol Biomark Prev 9 (2000) 339
29. Ali R.B., Teo A.K.C., Oh H.K., Chuang L.S.H., Ayi T.C., and Li B.F. Implication of localization of human DNA repair enzyme O6-methylguanine-DNA methyltransfersase at active transcription sites in transcription-repair coupling of the mutageneic O6-methylguanine lesion. Mol Cell Biol 18 (1998) 1660
30. Chen Z.P., Malapetsa A., McQuillan A., et al. Evidence for nucleotide excision repair as a modifying factor of O6-methylguanine-DNA transferase-medicated innate chloroethylnitrosourea resistance in human tumor cell lines. Mol Pharm 53 (1997) 815
31. Zhang H., Marra G., Jiricny J., Maher V.M., and McCormick J.J. Mismatch repair is required for O(6)-methylguanine-induced homologous recombination in human fibroblasts. Carcinogenesis 21 (2000) 1639
32. Figueiredo J.C., Knight J.A., Briollais L., Andrulis I.L., and Ozcelik H. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 13 (2004) 583
33. Smith T.R., Levine E.A., Perrier, et al. DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 12 (2003) 1200
34. Kuschel B., Auranen A., McBride S., et al. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Human Mol Genet 11 (2002) 1399
35. Forsti A., Angelini S., Festa F., et al. Single nucleotide polymorphisms in breast cancer. Oncol Reports 11 (2004) 917
36. Han J., Hankinson S.E., Ranu H., De Vivo I., and Hunter D.J. Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' health Study. Carcinogenesis 25 (2004) 189
37. Jacobsen N.R., Nexo B.A., Olsen A., et al. No association between the DNA repair gene XRCC3 T241M polymorphism and risk of skin cancer and breast cancer. Cancer Epidemiol Biomarkers Prev 12 (2003) 584
38. Colleu-Durel S., Guitton N., Nourgalieva K., et al. Alkaline single-cell gel electrophoresis (comet assay). A simple technique to show genomic instability in sporadic breast cancer. Eur J Cancer 40 (2004) 445
39. Helzlsouer K.J., Harris E.L., Parshad R., Perry H.R., Price F.M., and Sanford K.K. DNA repair proficiency. Potential susceptibility factor for breast cancer. J Natl Cancer Inst 88 (1996) 754
40. Rothfuss A., Schutz P., Bochum S., et al. Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res 60 (2000) 390
41. Smith T.R., Miller M.S., Lohman K.K., Case L.D., and Hu J.J. DNA damage and breast cancer risk. Carcinogenesis 24 (2003) 131
42. Trenz K., Schutz P., and Speit G. Radiosensitivity of lymphoblastoid cell lines with a heterozygous NRCA1 mutation is not detected by the comet assay and pulsed field gel electrophoresis. Mutagenesis 20 (2005) 131
43. Roy S.K., Trivdei A.H., Bakshi S.R., et al. Bleomycin-induced chromosome damage in lymphocytes indicated inefficient DNA repair capacity in breast cancer families. J Exp Clin Cancer Res 19 (2000) 169